Navigation Links
Verenium and Add Food Service GmbH Announce Commercial Distribution Partnership for Fuelzyme(R) and Veretase(TM) Enzymes

- Focus on the development and distribution of enzymes for starch processing and starch-based ethanol production in Europe -

CAMBRIDGE, Mass. and ASCHEBERG, Germany, June 22 /PRNewswire-FirstCall/ -- Verenium Corporation (Nasdaq: VRNM), a pioneer in the development of next-generation cellulosic ethanol and high-performance specialty enzymes, and Add Food Service GmbH today announced that they have signed a multi-product distribution agreement. Add Food Service is a leading enzyme solutions company for both industrial and food applications primarily in Europe and South America. Under the agreement, Add Food Service will distribute Fuelzyme and Veretase in Europe and other selected geographies outside of North America. In addition, Verenium and Add Food Service GmbH are jointly pursuing the development of additional enzyme products for starch processing and the starch-based ethanol industry in both Europe and North America.

"Verenium welcomes the opportunity to work with Add Food Service for the distribution of Fuelzyme and Veretase," said Janet Roemer, Verenium's Executive Vice President, Specialty Enzymes Business. "By partnering with Add Food, Verenium is working to ensure that our current alpha amylase products are able to achieve maximum global market penetration. "In addition, bringing together the two companies for the development of new innovative enzyme products for starch processing is an opportunity to benefit both businesses over the long-term," she added.

Fuelzyme and Veretase alpha amylases are high performance enzymes for the liquefaction of starch-based mashes and slurries for use in fuel ethanol (Fuelzyme) and food and beverage (Veretase) applications. Verenium will continue to directly market and sell these products in North America.

About Fuelzyme Alpha Amylase

Fuelzyme alpha amylase is a unique high performance enzyme designed to significantly improve the efficiency and economics of fuel ethanol production. Fuelzyme provides exceptional mash viscosity reduction, at a much lower dose, compared to competitive products and is effective over an exceptionally wide temperature and pH range allowing ethanol producers greater operational flexibility. Fuelzyme is an extremely thermostable alpha amylase with a unique mode of action for starch breakdown enabling ethanol producers to achieve significant enzyme dose reductions resulting in sizeable enzyme cost savings. Furthermore, the ability of Fuelzyme to effectively perform mash liquefaction at a much lower pH than competitor products can reduce chemical usage.

About Veretase Alpha Amylase

Veretase alpha amylase is a high performance enzyme designed to significantly improve the efficiency and economics of sweetener and beverage alcohol production. With a unique mode of action this enzyme breaks down starch into a more uniform blend of lower molecular weight oligosaccharides, improving saccharification and fermentation efficiency and consistency. Veretase possesses extreme thermostability and low pH activity, and has been shown to be effective over an exceptionally wide temperature and pH range providing sweetener and beverage alcohol producers greater operational flexibility and reduced processing costs. Veretase also provides exceptional mash viscosity reduction at a much lower dose over competitive products.

About Verenium

Verenium Corporation is a leader in the development and commercialization of cellulosic ethanol, an environmentally-friendly and renewable transportation fuel, as well as high-performance specialty enzymes for applications within the biofuels, industrial, and animal health markets. The Company possesses integrated, end-to-end capabilities and cutting-edge technology in pre-treatment, novel enzyme development, fermentation and project development for next-generation biofuels. Through a joint venture with BP, the Company is moving rapidly to commercialize its proprietary technology for the production of ethanol from a wide array of non-food feedstocks, including dedicated energy crops, agricultural waste, and wood products. In addition to the vast potential for biofuels, a multitude of large-scale industrial opportunities exist for the Company for products derived from the production of low-cost, biomass-derived sugars.

Verenium's Specialty Enzyme business harnesses the power of enzymes to create a broad range of specialty products to meet high-value commercial needs. Verenium's world class R&D organization is renowned for its capabilities in the rapid screening, identification, and expression of enzymes-proteins that act as the catalysts of biochemical reactions. For more information on Verenium, visit

About Add Food Service GmbH

Add Food Service GmbH, headquartered in Ascheberg, Germany is an enzyme company providing enzyme solutions for both industrial and food applications primarily in Europe and South America. Add Food provides innovative enzyme solutions for fuel ethanol, beverage alcohol and starch processing as well as fruit juice processing and beer and wine production. For more information on Add Food Service, visit

Forward Looking Statements

Statements in this press release that are not strictly historical are "forward-looking" and involve a high degree of risk and uncertainty. These include, but are not limited to, statements related to the Company's operations, capabilities, commercialization activities, target markets, cellulosic ethanol facilities, and future financial performance, results and objectives, all of which are prospective. Such statements are only predictions, and actual events or results may differ materially from those projected in such forward-looking statements. Factors that could cause or contribute to the differences include, but are not limited to, risks associated with Verenium's technologies, risks associated with the costs, labor requirements and labor availability associated with Verenium's demonstration plant, risks associated with Verenium's ability to obtain additional capital to support its planned operations and financial obligations, risks associated with Verenium's dependence on patents and proprietary rights, risks associated with Verenium's protection and enforcement of its patents and proprietary rights, technological, regulatory, competitive and other risks related to development, production, and commercialization of cellulosic ethanol and other biofuels and the commercial prospects of those industries, Verenium's dependence on existing collaboration, manufacturing, and/or license agreements, and its ability to achieve milestones under existing and future collaboration agreements, the ability of Verenium and its partners to commercialize its technologies and products (including by obtaining any required regulatory approvals) using Verenium's technologies and timing for launching any commercial products and projects, the ability of Verenium and its collaborators to market and sell any products that it or they commercialize, the development or availability of competitive products or technologies, the future ability of Verenium to enter into and/or maintain collaboration and joint venture agreements and licenses, changes in the U.S. or global energy markets and laws and regulations applicable to them, and risks and other uncertainties more fully described in the Company's filings with the Securities and Exchange Commission, including, but not limited to, the Company's quarterly report on Form 10-Q for the three months ended March 31, 2009. These forward-looking statements speak only as of the date hereof, and the Company expressly disclaims any intent or obligation to update these forward-looking statements.

    Verenium Contacts:

    Kelly Lindenboom                    Sarah Carmody
    Vice President, Corporate           Sr. Corporate Communications
    Communications                      Associate
    617-674-5335                        617-674-5357

    Add Food Service Contact:
    Hans de Bie
    Managing Director

SOURCE Verenium Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Verenium Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2007
2. Governor Rendell Discusses Impact of Budget on Services for Families of Children With Autism
3. Blue Cross Blue Shield of Michigan Concludes Autism Lawsuit with Settlement Focused on Families Who Received Early Intervention Services, Not Attorneys
4. Arcadian Management Services Names CEO Robert Fahlman as Chairman of the Board
5. DaVita Launches First Corporate Social Responsibility Report With Nationwide Community Service Blitz
6. Millstone Medical Outsourcing Expands Capacity, Enhances Loaner Kit Processing Services with New Equipment
7. Englewood Hospital Home Health and Hospice Services Selects Cardiocom Telehealth Technology
8. Homefront Diabetic Services Completes Accreditation with ACHC
9. Epilepsy Services on the Chopping Block
10. Florida Dermatologists Announce Distinguished Service Award Winner
11. Health Care Service Corporation Names Carolyn H. Clift as Senior Vice President and First Chief Diversity Officer
Post Your Comments:
(Date:11/24/2015)... ... 2015 , ... The hospitals and health systems on this ... care. They have received recognition for excellence from various reputable organizations in areas ... Hospital Review selected hospitals for inclusion based on national rankings and awards from ...
(Date:11/24/2015)... ... 2015 , ... In response to recent news highlighting Oxycodone fraud, Novus Medical ... the United States grew 400 percent between 1999 and 2010, far more than the ... percent of all fatal drug overdoses. (1) , While oxycodone and the extended release ...
(Date:11/24/2015)... ... ... Serenity Point Rehabilitation, a holistic treatment center for substance abuse located in Marne, ... members at their recovery center. The videos highlight some of the various aspects of ... that make their recovery program so unique. , “Making the decision to seek treatment ...
(Date:11/24/2015)... ... November 24, 2015 , ... ... Cleveland University-Kansas City (CU-KC), in Overland Park, Kansas. Benson, a fifth-trimester ... University President Carl S. Cleveland III on October 16. , “Katie is very ...
(Date:11/24/2015)... ... 24, 2015 , ... Autism Speaks, the world’s leading autism science and advocacy ... and the generosity of people around the world. On December 1, supporters can make ... – and share the personal stories behind those gifts. , Just as Black ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... 2015  In the pharmaceutical industry, companies want to ... quickly uncover new insights, tactics and strategies that will ... --> However, organizations often find it is ... ensure that all rules and regulations are met to ... barrier to efficiently launching market research projects is the ...
(Date:11/24/2015)... , 24. November 2015 Avery ... Pacemaker Systems, ist erfreut, die Berufung von ... bekannt geben zu können. ... --> Foto - ... (Schweden). Von 1984-1986 war er Fellow des ...
(Date:11/24/2015)... Sectra (STO: SECT B) announces ... a multi-year agreement to deploy Breast Imaging PACS ... provide the Breast Center a future-proof platform capable of expanding ... B) announces that Breast Center of Acadiana has ... Imaging PACS in its two freestanding imaging centers. This investment ...
Breaking Medicine Technology: